The DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men
Open accessAbstract
Background— High-sensitivity C-reactive protein and family history are independently associated with future cardiovascular events and have been incorporated into risk prediction models for women (the Reynolds Risk Score for women); however, no cardiovascular risk prediction algorithm incorporating these variables currently exists for men. Methods and Results— Among 10 724 initially healthy American nondiabetic men who were followed up prospectively over a median period of 10.8 years, we compared the test characteristics of global model fit, discrimination, calibration, and reclassification in 2 prediction models for incident cardiovascular events, one based on age, blood pressure, smoking status, total cholesterol, and high-density lipoprotein cholesterol (traditional model) and the other based on these risk factors plus high-sensitivity C-reactive protein and parental history of myocardial infarction before age 60 years (Reynolds Risk Score for men). A total of 1294 cardiovascular events accrued during study follow-up. Compared with the traditional model, the Reynolds Risk Score had better global fit (likelihood ratio test P <0.001), a superior (lower) Bayes information criterion, and a larger C-index ( P <0.001). For the end point of all cardiovascular events, the Reynolds Risk Score for men reclassified 17.8% (1904/10 724) of the study population (and 20.2% [1392/6884] of those at 5% to 20% 10-year risk) into higher- or lower-risk categories, with markedly improved accuracy among those reclassified. For this model comparison, the net reclassification index was 5.3%, and the clinical net reclassification index was 14.2% (both P <0.001). In models based on the Adult Treatment Panel III preferred end point of coronary heart disease and limited to men not taking lipid-lowering therapy, 16.7% of the study population (and 20.1% of those at 5% to 20% 10-year risk) were reclassified to higher- or lower-risk groups, again with significantly improved global fit, larger C-index ( P <0.001), and markedly improved accuracy among those reclassified. For this model, the net reclassification index was 8.4% and the clinical net reclassification index was 15.8% (both P <0.001). Conclusions— As previously shown in women, a prediction model in men that incorporates high-sensitivity C-reactive protein and parental history significantly improves global cardiovascular risk prediction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many risk assessment systems are available and have been comprehensively reviewed, including different Framingham models, 41 Systemic Coronary Risk Estimation (SCORE), 42 ASSIGN (CV risk estimation model from the Scottish Intercollegiate Guidelines Network), 43 Q-Risk, 44 Prospective Cardiovascular Munster Study (PROCAM), 45 Reynolds, 46,47 CUORE, 48 the Pooled Cohort equations 49 and Globorisk. 5”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,156
Self-citationRidker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–840 of 840
Dose Myocardial MIBI Washout Rate Has Relation to Risk Stratification of Coronary Artery Disease.
Moustafa, M., & Omar, M. (2018) · The Egyptian Journal Nuclear Medicine · doi:10.21608/egyjnm.2018.46186
Helmi, M. F. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Initial Evaluation and Approach to the Patient with Hypertension
Krousel-Wood, M. A., & Oparil, S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00028-x
Inflammatory Markers Associated with Disease Progression of Cardiorenal Syndrome
Banerjee, S. K., Patel, R., & Panas, R. M. (2015) · ScholarWorks (Walden University) · doi:10.13140/2.1.2561.8726
Hypercholesterolemia at a young age
Spiridonov, A. N., & Ragino, Y. I. (2021) · Ateroscleroz · doi:10.52727/2078-256x-2021-17-2-83-93
Inflammatory profiles in acute coronary syndromes
Kristono, G. A. (2021) · Otago University Research Archive (University of Otago)
Nontraditional risk factors of coronary artery disease among Palestinians: A case-control study
Khadoura, K. J., Kahlout, A., & Habib, M. (2021) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2021.10.004
Nambi, V., Chambless, L. E., Folsom, A. R., He, M. M., Hu, Y., Mosley, T. H., Volcik, K. A., Boerwinkle, E., & Ballantyne, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.013
(2018) · Wiley eBooks · doi:10.1002/9781118829875.refs
Quispe, R., Das, T. M., & Michos, E. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-75055-8_2
Atherosclerotic Plaque Imaging
Lavín, B., Phinikaridou, A., Andía, M. E., Lacerda, S., Henningsson, M., Makowski, M. R., & Botnar, R. M. (2019) · Contemporary cardiology · doi:10.1007/978-1-4939-8841-9_14
Epidemiology of Atherosclerotic Vascular Disease
Andersson, C., & O’Donnell, C. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_46-1
Total 10-year risk of death from cardiovascular disease in 25—64 year-old men in Tyumen
Pushkarev, G. S., Анатольевич, К. В., & Викторовна, А. Е. (2020) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20202301184
Li, D. ‘. (2018) · Springer eBooks · doi:10.1007/978-3-319-68379-9_7
Circulating Vascular Endothelial Growth Factor-1 in Cardiovascular Disease
Berezin, A. Е. (2016) · Springer eBooks · doi:10.1007/978-94-007-7678-4_2
C-reactive protein: a predictive marker, not a causal factor, for cardiovascular disease
(2009) · Nature Reviews Cardiology · doi:10.1038/ncpcardio1425
Ethnic Factors in the Assessment of Cardiovascular Risk for Primary Prevention
Bhatia, H. S., Xu, I., Taub, P. R., & Wilkinson, M. J. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_11
Manavalan, A. D. (2022) · Springer eBooks · doi:10.1007/978-3-031-15353-2_9
Ridker, P. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00031-1
Self-citationBraun, L. T., & Lloyd‐Jones, D. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-53705-9_9
Cardiovascular risk stratification in Indian subjects: Lessons learned and the way forward
Kaushik, M., Bansal, M., & Kasliwal, R. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95469-3.00011-5
CORRELATION BETWEEN FERRITIN, IL-6 AND IL-1Β
Filho, M. F. G. J. (2024) · Health and Society · doi:10.51249/hs.v4i06.2318
Wang, C., Wang, Y., & Zhang, W.-B. (2024) · International Heart Journal · doi:10.1536/ihj.24-271
Ushakov, A. V., ZAKHARYAN, E. A., Grigoriev, P. E., & Malyi, K. D. (2025) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2025-1-96-104
Kurt, B., Rau, M., Hartmann, O., Bergmann, A., Reugels, M., Just, S., Wenzl, F. A., Moellmann, J., Spießhöfer, J., Milzi, A., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120220
Cardiovascular Disease Genetic Risk Prediction Models: A Systematic Review
Khan, S., & Zhan, X. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1010866
Punnen, G., Mane, M. S., Irodi, A., Chacko, B. R., Vimala, L. R., George, P. V., & Joseph, E. (2025) · Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging · doi:10.4103/jiae.jiae_13_25
Cardiovascular risk prediction in Central and Eastern Europe and former Soviet Union
Vikhireva, O. (2012) · UCL Discovery (University College London)
Martínez, J. C. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Charalambous, M., Filler, R., Soteriades, E. S., Abitria, R., Kiser, J., Fernandez-Montero, A., Kales, S. N., & Smith, D. L. (2026) · Cureus · doi:10.7759/cureus.101388
Primary Prevention in Older Adults
Parsons, B., Soni, S., Rao, S., & Mehta, A. (2026) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.12.010
Berg, D. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00008-2
Assessment of Cardiovascular Disease Risk Across the Lifespan
Tapp, D. N., Haygood, D., Tipler, P., Tzoumas, A., & Quesada, O. (2026) · Springer eBooks · doi:10.1007/978-3-032-18203-6_2
Wang, S., Li, T., & Huang, H. (2026) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2026.2708886
Guo, J., Bao, C., Gong, L., & Zhang, Z. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1892900
Cai, X., Zhang, J., Huang, H., Tang, W., Lv, Q., Song, Y., Zhang, X., Cai, Q.-C., Zou, J., Shi, Y., et al. (2026) · MedComm · doi:10.1002/mco2.70967
Perspectives on Cholesterol Guidelines
Grundy, S. M. (2015) · Contemporary Endocrinology · doi:10.1007/978-1-60761-424-1_18
Warum die rheumatoide Arthritis den Kardiologen braucht
Pieringer, H., & Hoppe, U. C. (2013) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-013-1198-6
Metadata
- Authors
- Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- Circulation
- Published
- 2008-11-25
- Volume
- 118
- Issue
- 22
- Pages
- 2243-2251
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC2752381
- OpenAlex
- W2096807144
- Semantic Scholar
- 4e13b2445d617740f45915eafd75712fdf825998
- Cited by
- 841
- References
- 27
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 20 · 2023: 25 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 39 · 2018: 42 · 2017: 37 · 2016: 47 · 2015: 68 · 2014: 63 · 2013: 53 · 2012: 92
- FWCI
- 80.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA097193)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- Reynolds Risk Score, cardiovascular risk prediction, men, family history of myocardial infarction, coronary artery disease, risk reclassification, net reclassification improvement, coronary risk factors, hypertriglyceridemia, hypercholesterolemia, LDL cholesterol, HDL cholesterol, blood pressure, smoking, non-diabetic men
- MeSH terms
- C-Reactive Protein, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Inflammation, Life Style, Male, Predictive Value of Tests, Prospective Studies, Sex Characteristics, Biomarkers, Likelihood Functions, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
